Barnadas, A. http://orcid.org/0000-0002-0429-1349
,
Muñoz, M.
Margelí, M.
Chacón, J. I.
Cassinello, J.
Antolin, S.
Adrover, E.
Ramos, M.
Carrasco, E.
Jimeno, M. A.
Ojeda, B.
González, X.
González, S.
Constenla, M.
Florián, J.
Miguel, A.
Llombart, A.
Lluch, A.
Ruiz-Borrego, M.
Colomer, R.
Del Barco, S.
Funding for this research was provided by:
Novartis Spain (na)
GEICAM Spanish Breast Cancer Group (na)
Roche Spain (na)
Article History
Received: 29 May 2019
Accepted: 15 November 2019
First Online: 21 December 2019
Ethics approval and consent to participate
: The study followed the <i>International Guidelines for Ethical Review of Epidemiological Studies</i> and the guidelines of the Spanish Epidemiological Society. The protocol was approved by the Institutional Review Board of each participating institution. Written informed consent was obtained before enrolling in the study.
: Not applicable.
: The authors declare that they have no competing interests.